CLINICAL_TRIALS
trial_result
· 2024-11-21
Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of AZD7442 in Chinese Adults [Phase 2]
Summary
A Phase 2 study evaluating the safety and tolerability of AZD7442 in Chinese adults has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AstraZeneca | Conditions: Coronavirus Disease 2019 (COVID-19) | Phase 2 | Status: COMPLETED | Results posted: 2024-11-21